Unichem Laboratories Limited
UNICHEMLAB.BO- 1D
- -1.5%
Unichem Laboratories Limited in brief
Unichem Laboratories Limited is a listed company in the Pharmaceutical industry, based in India. Its market value was $356 M on 20 November 2026, which makes it the 14,024th largest listed company in the world and the 1,034th largest in India on this site.
Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.
Unichem Laboratories Limited timeline
- 2001
- ๐Listed on National Stock Exchange of India as UNICHEMLABFirst day of listing in the exchange's official list.
Events of Unichem Laboratories Limited from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Unichem Laboratories Limited share price ยท NSE (UNICHEMLAB.NS)
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Nov 20, 2026 | 472.70 | 477.95 | 465.00 | 468.95 | -2.1% | 16,702 |
| Nov 19, 2026 | 478.00 | 484.80 | 474.00 | 479.25 | +0.0% | 12,709 |
| Nov 18, 2026 | 474.95 | 488.00 | 473.00 | 479.10 | -0.5% | 17,306 |
| Nov 17, 2026 | 488.90 | 490.00 | 475.10 | 481.55 | -0.7% | 29,319 |
| Nov 16, 2026 | 494.90 | 495.15 | 481.15 | 484.90 | -2.8% | 47,042 |
| Nov 13, 2026 | 500.05 | 510.00 | 496.15 | 498.75 | +0.3% | 40,490 |
| Nov 12, 2026 | 505.75 | 511.85 | 495.00 | 497.10 | -2.1% | 40,918 |
| Nov 11, 2026 | 510.00 | 511.80 | 501.10 | 507.95 | -0.2% | 26,948 |
| Nov 9, 2026 | 501.70 | 526.95 | 500.45 | 509.15 | +1.5% | 52,161 |
| Nov 6, 2026 | 485.55 | 513.00 | 485.00 | 501.70 | +1.7% | 84,039 |
| Nov 5, 2026 | 508.00 | 511.90 | 491.40 | 493.30 | -2.4% | 51,211 |
| Nov 4, 2026 | 508.85 | 542.10 | 490.45 | 505.45 | +0.4% | 452,254 |
| Nov 3, 2026 | 503.05 | 514.65 | 500.00 | 503.35 | -0.1% | 29,571 |
| Nov 2, 2026 | 483.75 | 509.00 | 482.45 | 503.85 | +4.2% | 29,023 |
| Oct 30, 2026 | 504.00 | 507.25 | 480.10 | 483.75 | -4.2% | 29,181 |
| Oct 29, 2026 | 488.80 | 510.00 | 487.00 | 504.95 | +3.3% | 38,035 |
| Oct 28, 2026 | 489.95 | 501.85 | 480.00 | 488.80 | +1.6% | 35,539 |
| Oct 27, 2026 | 477.00 | 488.95 | 474.45 | 481.10 | +1.4% | 14,310 |
| Oct 26, 2026 | 468.00 | 480.00 | 460.55 | 474.65 | +0.4% | 36,103 |
| Oct 23, 2026 | 481.25 | 489.00 | 461.70 | 472.95 | -3.0% | 40,084 |
| Oct 22, 2026 | 509.95 | 509.95 | 480.20 | 487.75 | -3.3% | 44,302 |
| Oct 21, 2026 | 502.20 | 515.00 | 473.45 | 504.65 | +0.0% | 113,058 |
| Oct 19, 2026 | 510.55 | 517.00 | 501.50 | 504.40 | -1.2% | 28,397 |
| Oct 16, 2026 | 523.85 | 523.85 | 505.05 | 510.55 | -2.0% | 48,083 |
| Oct 15, 2026 | 522.95 | 524.95 | 518.45 | 521.20 | +0.3% | 20,421 |
| Oct 14, 2026 | 530.00 | 530.00 | 518.00 | 519.70 | -1.3% | 26,429 |
| Oct 13, 2026 | 530.05 | 532.50 | 520.00 | 526.35 | -0.7% | 27,657 |
| Oct 12, 2026 | 530.50 | 540.95 | 525.50 | 529.90 | -0.2% | 23,650 |
| Oct 9, 2026 | 534.00 | 539.50 | 519.00 | 531.10 | +0.0% | 74,517 |
| Oct 8, 2026 | 548.00 | 568.95 | 526.10 | 530.90 | โ | 164,167 |
Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.
Unichem Laboratories Limited share price statistics
Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.
Market cap history
World rank over time
Rank in India: #620 (Jan 2020) ยท #548 (Jan 2021) ยท #746 (Jan 2022) ยท #751 (Dec 2022) ยท #741 (Jul 2023) ยท #765 (Jan 2024) ยท #807 (Mar 2026) ยท #1,007 (Nov 2026) ยท #1,006 (Nov 2026) ยท #1,019 (Nov 2026) ยท #1,018 (Nov 2026) ยท #1,016 (Nov 2026) ยท #1,018 (Nov 2026) ยท #1,030 (Nov 2026)
Mutual funds holding Unichem Laboratories Limited#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| ๐ฎ๐ณ DSP Healthcare FundDSP Asset Managers | 1.13 M | $6 M | โ | 1.5% | +0.1% | Oct 31, 2026 |
| ๐บ๐ธ Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP | 191,703 | $1 M | โ | <0.01% | โ1.2% | Jul 31, 2026 |
| ๐บ๐ธ Dimensional Emerging Markets Value FundDimensional Fund Advisors LP | 146,926 | $1 M | โ | <0.01% | no change | Jul 31, 2026 |
| ๐บ๐ธ The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP | 91,800 | $0 M | โ | 0.01% | no change | Jul 31, 2026 |
| ๐บ๐ธ State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc. | 28,288 | $0 M | โ | 0.02% | no change | Jun 30, 2026 |
| ๐บ๐ธ Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 10,202 | $0 M | โ | <0.01% | no change | Jul 31, 2026 |
| ๐บ๐ธ World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP | 9,550 | $0 M | โ | <0.01% | no change | Jul 31, 2026 |
| ๐บ๐ธ Emerging Markets Social Core Equity PortfolioDimensional Fund Advisors LP | 9,330 | $0 M | โ | <0.01% | no change | Jul 31, 2026 |
| ๐บ๐ธ Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP | 8,751 | $0 M | โ | <0.01% | โ24% | Jul 31, 2026 |
| ๐บ๐ธ World ex U.S. Targeted Value PortfolioDimensional Fund Advisors LP | 7,286 | $0 M | โ | <0.01% | no change | Jul 31, 2026 |
| ๐บ๐ธ Emerging Markets ex China Core Equity PortfolioDimensional Fund Advisors LP | 5,682 | $0 M | โ | <0.01% | no change | Jul 31, 2026 |
| ๐บ๐ธ Avantis Responsible Emerging Markets Equity ETFAmerican Century ETF Trust | 1,194 | $0 M | โ | <0.01% | no change | May 31, 2026 |
| ๐บ๐ธ Dimensional Emerging Markets ex China Core Equity ETFDimensional Fund Advisors LP | 80 | $0 M | โ | <0.01% | no change | Jul 31, 2026 |
As of Oct 31, 2026
FDA drug approvals: Unichem Laboratories Limited#
72 approved applications held; 2 approvals and 0 new uses in 2026.
| Approved | Drug | Kind |
|---|---|---|
| 2026-07-13 | AlprazolamAlprazolam ยท ANDA213204 | Generic drug (ANDA) |
| 2026-04-30 | PregabalinPregabalin ยท ANDA219593 | Generic drug (ANDA) |
| 2024-11-19 | Guanfacine HydrochlorideGuanfacine Hydrochloride ยท ANDA219033 | Generic drug (ANDA) |
| 2024-09-10 | Cetirizine Hydrochloride And Pseudoephedrine HydrochlorideCetirizine Hydrochloride, Pseudoephedrine Hydrochloride ยท ANDA210507 | Generic drug (ANDA) |
| 2024-09-04 | LacosamideLacosamide ยท ANDA213109 | Generic drug (ANDA) |
| 2024-08-27 | Tolterodine TartrateTolterodine Tartrate ยท ANDA216917 | Generic drug (ANDA) |
| 2024-01-10 | Doxazosin MesylateDoxazosin Mesylate ยท ANDA212329 | Generic drug (ANDA) |
| 2023-08-28 | Prasugrel HydrochloridePrasugrel Hydrochloride ยท ANDA213315 | Generic drug (ANDA) |
| 2023-03-16 | RanolazineRanolazine ยท ANDA213083 | Generic drug (ANDA) |
| 2022-10-13 | Extended Phenytoin SodiumPhenytoin Sodium ยท ANDA213834 | Generic drug (ANDA) |
| 2022-08-22 | CarbamazepineCarbamazepine ยท ANDA213284 | Generic drug (ANDA) |
| 2022-08-15 | Quetiapine FumarateQuetiapine Fumarate ยท ANDA215478 | Generic drug (ANDA) |
| 2022-08-08 | Labetalol HydrochlorideLabetalol Hydrochloride ยท ANDA212719 | Generic drug (ANDA) |
| 2022-03-15 | Nebivolol HydrochlorideNebivolol Hydrochloride ยท ANDA213830 | Generic drug (ANDA) |
| 2022-02-25 | Divalproex SodiumDivalproex Sodium ยท ANDA214643 | Generic drug (ANDA) |
| 2021-12-01 | AripiprazoleAripiprazole ยท ANDA203025 | Generic drug (ANDA) |
| 2021-08-11 | Metformin HydrochlorideMetformin Hydrochloride ยท ANDA213359 | Generic drug (ANDA) |
| 2021-05-19 | Amitriptyline HydrochlorideAmitriptyline Hydrochloride ยท ANDA214548 | Generic drug (ANDA) |
| 2021-03-30 | MetolazoneMetolazone ยท ANDA214799 | Generic drug (ANDA) |
| 2021-03-03 | Guanfacine HydrochlorideGuanfacine Hydrochloride ยท ANDA214689 | Generic drug (ANDA) |
| 2021-02-17 | ApremilastApremilast ยท ANDA211819 | Generic drug (ANDA) |
| 2021-01-26 | ZonisamideZonisamide ยท ANDA214492 | Generic drug (ANDA) |
| 2021-01-12 | CelecoxibCelecoxib ยท ANDA213301 | Generic drug (ANDA) |
| 2020-11-25 | Atenolol And ChlorthalidoneAtenolol, Chlorthalidone ยท ANDA213302 | Generic drug (ANDA) |
| 2020-11-24 | EtodolacEtodolac ยท ANDA212263 | Generic drug (ANDA) |
How Unichem Laboratories Limited compares in Pharmaceutical
- Market cap$356 M ยท higher than 30% of 393
Peer comparison ยท Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Unichem Laboratories Limited๐ฎ๐ณ | $356 M | โ | โ | โ |
| Eli Lilly and Company๐บ๐ธ | $1.20 T | 43.4ร | 31.9% | +44.7% |
| Johnson & Johnson๐บ๐ธ | $652.5 B | 40.5ร | 16.2% | +6.0% |
| AbbVie Inc.๐บ๐ธ | $514.0 B | 49.7ร | 15.7% | +8.6% |
| Roche Holding AG๐จ๐ญ | $370.3 B | 29.1ร | 19.0% | โ |
| Merck & Co., Inc.๐บ๐ธ | $359.8 B | 146.7ร | 3.6% | +1.3% |
| Novartis AG๐จ๐ญ | $286.8 B | 20.5ร | 24.7% | โ |
| Amgen Inc.๐บ๐ธ | $249.2 B | 26.5ร | 24.1% | +9.9% |
| AstraZeneca PLC๐ฌ๐ง | $242.6 B | 23.7ร | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
How current the figures are
- Market cap:
- Nov 20, 2026
- Profile updated:
- Nov 22, 2026
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Unichem Laboratories Limited? Verify and update this profile โ free
Show Unichem Laboratories Limited's ranking on your website Get the badge
The badge updates itself as the ranking changes.